Acta Univ. Agric. Silvic. Mendelianae Brun. 2015, 63(6), 2011-2015 | DOI: 10.11118/actaun201563062011

Business Ethics and CSR in Pharmaceutical Industry in the Czech Republic and Hungary?

Markéta Lőrinczy, Sylvie Formánková
Department of Management, Faculty of Business and Economics, Mendel University in Brno, Zemědělská 1, 613 00 Brno, Czech Republic

How do business ethics and CSR form part of pharmaceutical business in the Czech Republic and Hungary? The question was analyzed through empirical studies where surveys were the main tool. The research investigated business ethics, CSR, ethical code, ethical involvement of employees as factors that might be important to achieve ethical behaviour in the pharmaceutical industry. Results showed that, with 69.4% response rate, that Czech and Hungarian original companies are more towards ethical behaviour and the employees know more about the organization they work for. The data were compared with parametric statistical analysis based on Mann-Whitney U calculator.

Keywords: business ethics, CSR, pharmaceutical industry
Grants and funding:

This paper was supported by Grant Agency International Visegrad Fund [No. 21310446].

Prepublished online: December 26, 2015; Published: January 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Lőrinczy, M., & Formánková, S. (2015). Business Ethics and CSR in Pharmaceutical Industry in the Czech Republic and Hungary? Acta Universitatis Agriculturae et Silviculturae Mendelianae Brunensis63(6), 2011-2015. doi: 10.11118/actaun201563062011
Download citation

References

  1. CARLAT, D. 2015. Hot Topics in Pharmaceutical Industry. PsychCentral.com. [Online]. PsychCentral, 2015. Available at: http://pro.psychcentral.com/hot-topics-in-pharmaceutical-industry-ethics/004479.html#. [Accessed: February 2, 2015].
  2. CHARLESWORTH, M. and SEWRY, D. 2004. South African IT Industry Professionals' Ethical Awareness: An Exploratory Study. Proceedings of SAICSIT 2004.
  3. CRANE, A., MATTEN, D. 2010. Business Ethics. 3rd edition. New York: Oxford University Press.
  4. DAVIDOVA, J., PRAZNOVCOVA, L., LUNDBORG, C. S. 2008. Pricing and reimbursement of pharmaceutical market in the Czech republic and Sweden. Pharmacy World and Science, 30(1): 57-64. DOI: 10.1007/s11096-007-9141-z Go to original source...
  5. DU NING-NING. 2014. Study on the realization of enterprise social responsibility. Journal of Chemical and Pharmaceutical Research, 1479-1483.
  6. FORMÁNEK, J. 2014. Keryx Biopharmaceuticals a co bude dál? Kurzycz. [Online]. Kurzy.cz, September 8, 2014. Available at: http://www.kurzy.cz/zpravy/370904-keryx-biopharmaceuticals-a-co-bude-dal/. [Accessed: January 30, 2015].
  7. FÜLÜP, G., HISRICH, R. B., SZEGEDI, K. 2000. Business ethics and social responsibility in transition economies. Journal of Management Development, 1(19): 1-3. Go to original source...
  8. GOODCORPORATION. 2013. GFK Rairness Index Survey. Goodcorporation.com. [Online]. Goodcorporation, 2013. Available at: http://goodcorporation.com/. [Accessed: January 24, 2015.]
  9. KAY, S. and POPKIN, S. J. 1998. Integrating ethics into the strategic management process: Doing well by doing good. Management Decision, 36(5): 331-338. DOI: 10.1108/00251749810220531 Go to original source...
  10. KPMG. 2015. Fraud and Misconduct Investigations. KPMG.com. [Online]. KPMG, 2015. Available at: http://www.kpmg.com/cn/en/services/advisory/transactions-restructuring/forensic/pages/fraud-and-misconduct-investigations.aspx. [Accessed: February 1, 2015.]
  11. LŐRINCZY, M. 2013. Impact of the crisis on the pharmaceutical market in the Czech republic and Hungary. Forum Scientiae Oeconomia, 1(2): 21-33.
  12. LŐRINCZY, M. et al. 2015. Trends of Business Ethics and Corporate Social Responsibility in Central Europe. Aachen: Shaker Verlag.
  13. MATHIS, R. L., JACKSON, J. H. 2010. Human Resources Management. Manson: South-Western Cengage Learning.
  14. NÁRODNÍ VZDĚLÁVACÍ FOND. 2015. Farmaceutický průmysl: Budouctnostprofesí.cz. [Online]. Available at: http://www.budoucnostprofesi.cz/cs/vyvoj-v-odvetvich/leciva.html. [Accessed: February 5, 2015].
  15. VELVERDE, J. L. 2012. Corporate responsibility and pharmaceutical fraud. Pharmaceuticals Policy and Law, 14: 129-156. Go to original source...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY NC ND 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.